FDA Inspection
David P. Walling, Ph.D.David P. Walling, Ph.D. – FDA Inspection, May 14, 2021
Record Details
This FDA Inspection record concerns David P. Walling, Ph.D., with an inspection on May 14, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- David P. Walling, Ph.D.
- Inspection Date
- May 14, 2021
- Product Type
- Drugs
View Company Profile
ID · 54182797-6a79-4873-bd3e-4a0388d50a92
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1143823
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of David P. Walling, Ph.D.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| January 13, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 19, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 11, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 23, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 9, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for David P. Walling, Ph.D.
- FDA Inspection 1195349 - 2023-01-13
- FDA Inspection 1063079 - 2018-03-19
- FDA Inspection 917428 - 2015-03-11
- FDA Inspection 911140 - 2015-01-23
- FDA Inspection 879347 - 2014-05-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.